The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.50BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing P/E
91.08x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Revenue (TTM)
1.58BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Profit Margin
3.19%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Beta
1.22x
vs all stocks
Updated Sep 27, 2026
52-Week Change
118.45%
vs all stocks
Updated Sep 27, 2026
Market Capitalization
4.50BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Enterprise Value
4.77BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing P/E
91.08x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Forward P/E
22.31x
vs Medical Care Facilities peers
Updated Sep 27, 2026
PEG Ratio
-0.1301x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Price to Sales (TTM)
2.84x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Price to Book (MRQ)
3.06x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Enterprise to Revenue
3.01x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Enterprise to EBITDA
35.34x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Gross Margin
35.15%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Profit Margin
3.19%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Operating Margin
7.25%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Return on Assets (TTM)
2.32%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Return on Equity (TTM)
3.43%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Revenue (TTM)
1.58BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue per Share (TTM)
4.10USDUpdated Sep 27, 2026
Quarterly Revenue Growth
26.10%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Gross Profit (TTM)
531.85MUSD
vs all stocks (USD)
Updated Sep 27, 2026
EBITDA (TTM)
132.68MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Net Income (TTM)
50.60MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Operating Cash Flow (TTM)
217.87MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Levered Free Cash Flow (TTM)
172.36MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 27, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Sep 27, 2026
Revenue
1.42BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
963.19MUSDFY2025 · Dec 31, 2025
Gross Profit
461.10MUSDFY2025 · Dec 31, 2025
Operating Income
24.15MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
12.36MUSDFY2025 · Dec 31, 2025
Income Tax Expense
2.70MUSDFY2025 · Dec 31, 2025
Net Income
9.66MUSDFY2025 · Dec 31, 2025
EBIT
24.02MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
78.78MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
382.20MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.66MUSDFY2025 · Dec 31, 2025
EPS (Basic)
0.0300USDFY2025 · Dec 31, 2025
EPS (Diluted)
0.0200USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
386.02MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
386.02MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
9.66MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
172.90MUSDFY2025 · Dec 31, 2025
Free Cash Flow
136.77MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
248.64MUSDFY2025 · Dec 31, 2025
Income Tax Paid
1.57MUSDFY2025 · Dec 31, 2025
Interest Paid
17.80MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
9.66MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
54.75MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
2.42MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
74.70MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
44.96MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
36.09MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-1.56MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-48.13MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-36.13MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-36.13MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.25MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-8.71MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-15.96MUSDFY2025 · Dec 31, 2025
Shares Outstanding
382.02MSharesUpdated Sep 27, 2026
Float Shares
267.08MSharesUpdated Sep 27, 2026
Shares Short
16.26MSharesUpdated Sep 27, 2026
Short Ratio
3.81days
vs all stocks
Updated Sep 27, 2026
Short % of Shares Outstanding
8.90%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 4.26%.Updated Sep 27, 2026
% Held by Insiders
3.15%
vs all stocks
Updated Sep 27, 2026
% Held by Institutions
95.68%
vs all stocks
Updated Sep 27, 2026
Total Cash (MRQ)
225.94MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Cash per Share (MRQ)
0.5910USDUpdated Sep 27, 2026
Total Debt (MRQ)
474.15MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Debt to Equity (MRQ)
0.3210x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Current Ratio (MRQ)
1.38x
vs Medical Care Facilities peers
Updated Sep 27, 2026
Book Value per Share (MRQ)
3.87USDUpdated Sep 27, 2026
Total Assets
2.20BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
416.20MUSDFY2025 · Dec 31, 2025
Total Liabilities
682.92MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.79BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
430.96MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
251.96MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
248.64MUSDFY2025 · Dec 31, 2025
Accounts Receivable
95.71MUSDFY2025 · Dec 31, 2025
Accounts Payable
18.85MUSDFY2025 · Dec 31, 2025
Short-term Debt
60.04MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
282.00KUSDFY2025 · Dec 31, 2025
Long-term Debt
414.48MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
68.00KUSDFY2025 · Dec 31, 2025
Common Stock (Book)
3.88MUSDFY2025 · Dec 31, 2025
Retained Earnings
-808.63MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.52BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.77USDUpdated Sep 27, 2026
52-Week High
13.56USDUpdated Sep 27, 2026
52-Week Change
118.45%
vs all stocks
Updated Sep 27, 2026
Beta
1.22x
vs all stocks
Updated Sep 27, 2026
50-Day MA
11.97USDUpdated Sep 27, 2026
200-Day MA
8.67USDUpdated Sep 27, 2026
Avg 10-Day Volume
6.92MSharesUpdated Sep 27, 2026
Avg 30-Day Volume
5.08MSharesUpdated Sep 27, 2026
Diluted EPS (TTM)
0.1300USDUpdated Sep 27, 2026
Other Income / Expense
-123.00KUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
How does this company use capital?
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.21: safe zoneNotable
Altman Z-Score: 4.21
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $4.5B, above the global median of $1.18BNotable
Market cap (USD): 4,501,025,100Global Median: 1,180,223,658.953
Revenue is $1.58B, above the global median of $548.88MNotable